Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Physiol Pharmacol ; 2006 Oct-Dec; 50(4): 409-15
Article Dans Anglais | IMSEAR | ID: sea-106608

Résumé

The objective of the present study was to evaluate the antidepressant action of Withania somnifera (WS) as well as its interaction with the conventional antidepressant drugs and to delineate the possible mechanism of its antidepressant action using forced swimming model in mice. Effect of different doses of WS, fluoxetine and imipramine were studied on forced swimming test induced mean immobility time (MIT). Moreover effect of WS 100 mg/kg, i.p. was observed at different time intervals. Effect produced by combination of sub therapeutic doses of WS with imipramine (2.5 mg/kg, i.p.) as well as fluoxetine (2.5 mg/kg, i.p.) were also observed. Effect of WS (100 mg/kg, i.p.) as well as combination of WS (37.5 mg/kg, i.p.) with either imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.) were observed in mice pretreated with reserpine (2 mg/kg, i.p.) and clonidine (0.15 mg/kg, i.p.). Effects of prazosin (3 mg/kg, i.p.) or haloperidol (0.1 mg/kg, i.p.) pre-treatment were also observed on WS induced decrease in MIT. WS produced dose dependent decrease in MIT. Maximum effect in MIT was observed after 30 min of treatment with WS 100 mg/kg, i.p. Combination of WS (37.5 mg/kg, i.p.) with imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.) also produced significant decrease in the MIT. Clonidine and reserpine induced increase in MIT, was significantly reversed by treatment with WS (100 mg/kg, i.p.) as well as combination of WS (37.5 mg/kg, i.p.) with either imipramine (2.5 mg/kg, i.p.) or fluoxetine (2.5 mg/kg, i.p.). Pre-treatment with prazosin but not haloperidol, significantly antagonized the WS (100 mg/kg, i.p.) induced decrease in MIT. It is concluded that, WS produced significant decrease in MIT in mice which could be mediated partly through a adrenoceptor as well as alteration in the level of central biogenic amines.


Sujets)
Agonistes alpha-adrénergiques/pharmacologie , Antagonistes alpha-adrénergiques/pharmacologie , Animaux , Antidépresseurs , Antidépresseurs de seconde génération/pharmacologie , Antidépresseurs tricycliques/pharmacologie , Neuroleptiques/pharmacologie , Clonidine/pharmacologie , Interactions médicamenteuses , Femelle , Fluoxétine/pharmacologie , Imipramine/pharmacologie , Mâle , Souris , Activité motrice/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Prazosine/pharmacologie , Réserpine/pharmacologie , Natation/physiologie , Withania/composition chimique
2.
Indian J Med Sci ; 1970 Apr; 24(4): 208-13
Article Dans Anglais | IMSEAR | ID: sea-69002
3.
J Postgrad Med ; 1963 Apr; 9(): 79-82
Article Dans Anglais | IMSEAR | ID: sea-117130
SÉLECTION CITATIONS
Détails de la recherche